Zurcher Kantonalbank (Zurich Cantonalbank) Immuno Gen, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$12.46 - $29.95 $66,748 - $160,442	5,357 Added 11.98%	50,066 $1.48 Million
Q3 2023 Oct 25, 2023	BUY	$14.09 - $19.87 $100,729 - $142,050	7,149 Added 19.03%	44,709 $709,000
Q2 2023 Aug 07, 2023	BUY	$3.75 - $20.05 $27,945 - $149,412	7,452 Added 24.75%	37,560 $708,000
Q1 2023 May 08, 2023	SELL	$3.67 - $4.92 $11,766 - $15,773	-3,206 Reduced 9.62%	30,108 $115,000
Q4 2022 Feb 01, 2023	SELL	$4.55 - $6.31 $2,356 - $3,268	-518 Reduced 1.53%	33,314 $165,000
Q3 2022 Nov 09, 2022	BUY	$4.48 - $6.47 $41,605 - $60,086	9,287 Added 37.84%	33,832 $162,000
Q2 2022 Aug 09, 2022	SELL	$3.15 - $5.76 $34,215 - $62,565	-10,862 Reduced 30.68%	24,545 $110,000
Q1 2022 Apr 21, 2022	BUY	$4.26 - $7.48 $16,217 - $28,476	3,807 Added 12.05%	35,407 $169,000
Q4 2021 Feb 01, 2022	SELL	$4.75 - $7.5 $2,935 - $4,635	-618 Reduced 1.92%	31,600 $234,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $371 - $487	74 Added 0.23%	32,218 $183,000
Q2 2021 Jul 30, 2021	BUY	$5.79 - $8.6 $2,958 - $4,394	511 Added 1.62%	32,144 $212,000
Q1 2021 May 03, 2021	BUY	$6.5 - $10.53 $86,495 - $140,122	13,307 Added 72.61%	31,633 $256,000
Q2 2020 Jul 28, 2020	BUY	$3.32 - $5.34 $16,729 - $26,908	5,039 Added 37.92%	18,326 $84,000
Q1 2020 May 06, 2020	BUY	$2.12 - $6.8 $10,686 - $34,278	5,041 Added 61.13%	13,287 $45,000
Q1 2019 Apr 29, 2019	SELL	$2.41 - $5.91 $7,892 - $19,355	-3,275 Reduced 28.43%	8,246 $22,000
Q3 2018 Nov 09, 2018	BUY	$8.6 - $11.26 $17,845 - $23,364	2,075 Added 21.97%	11,521 $109,000
Q2 2018 Aug 06, 2018	SELL	$9.52 - $12.15 $16,164 - $20,630	-1,698 Reduced 15.24%	9,446 $92,000
Q1 2018 May 03, 2018	BUY	$6.7 - $12.95 $49,653 - $95,972	7,411 Added 198.53%	11,144 $117,000
Q3 2017 Nov 08, 2017	BUY	$5.4 - $8.47 $20,158 - $31,618	3,733	3,733 $29,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account